Sexual Function in Male Renal Transplant Patients

Status Terminated

Clinical Trial Summary

Sexual dysfunction is common in male patients with chronic renal failure on dialysis and after renal trasnplantation. Multiple factors play a role in this important clinical problem. Recent studies suggest that certain immunosuppressive medication used for solid organ transplant may affect male sexual function. The purpose of this study is to compare the sexual function of male renal transplant patients on sirolimus and those patients not on sirolimus immunosuppression.

Clinical Trial Description

All male renal transplant recipients with a functioning allograft 1 month post transplant will be eligible to participate in this prospective serial observation study. As roughly half of renal transplant patients are assigned to rapamycin immunnosuppression clinically and half are not, we plan to assess routine clinical perameters, sex hormone levels, subjective sexual function as measured by standardized questionnaire and semen analysis in 55 patients on sirolimus treatment and 55 patients not on this treatment. Assessment will be made at baseline (1 mo post transplant) and 6 and 12 months later. All adult male renal transplant recipients ages 21-65 off dialysis 1 mo post transplant will be eleigible. Exclusion criteria will be female gender, patients requiring testosterone therapy, patients on dialysis, and those unwilling to give informed consent. ;

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

Renal Transplant Recipients

Clinical Trial Details

NCT number	NCT00271830
Study type	Observational
Source	Montefiore Medical Center
Contact
Status	Terminated
Phase	N/A
Start date	January 2006
Completion date	August 2007

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT02956005` - Envarsus XR in African American Renal Transplant Recipients	N/A
Completed	`NCT01086904` - Safety and Efficacy of an Inactivated and Non Adjuvanted Vaccine Against Influenza A in Renal Transplant Recipients	Phase 2
Completed	`NCT00319189` - Efficacy and Safety of Nateglinide Treatment in Renal Transplant Recipients	Phase 4
Completed	`NCT01859832` - Validation of a Novel Diagnostic Tool for the Evaluation of Post Renal Transplant Immunosuppression: The ImmuKnow Assay	N/A
Recruiting	`NCT03110406` - Effects of Whole-body Vibration Training on the Heart Rate Variability Cardiac in Kidney Transplantation	N/A
Recruiting	`NCT02973464` - The Strategy in the Prevention of Renal Post-transplant Cytomegalovirus Infection Among Chinese Population	Phase 3
Active, not recruiting	`NCT03797196` - RCT Comparing Immunosuppressive Regimens in Elderly Renal Transplant Recipients	Phase 4
Terminated	`NCT01318915` - Research Study of ATG and Rituximab in Renal Transplantation	Early Phase 1
Recruiting	`NCT00327483` - Web Based Renal Transplant Patient Medication Education	Phase 4
Completed	`NCT00138970` - Calcineurin Inhibitor-Free Immunosuppression in Renal Transplant Recipients at Low Immunogenic Risk	Phase 4
Withdrawn	`NCT04903054` - Selective CD28 Blockade in Renal Transplant Recipients	Phase 2
Completed	`NCT02706678` - Efficacy and Safety Study of the Switch From Cyclosporin to Tacrolimus in Renal Transplant Recipients	Phase 4
Active, not recruiting	`NCT04218721` - Implementing eHealth Interventions Into Regular Clinical Practice	N/A
Recruiting	`NCT03726307` - Allogeneic Regulatory Dendritic Cell (DCreg) Renal Study	Phase 1